Compared to healthy controls, GPx3 expression is also lower in both the plasma and tumor tissue of non-small-cell lung cancer (NSCLC), glioblastoma, and hepatocellular carcinoma (HCC) patients [88,96,97]. The gene discussed is GPX3; the disease is neoplasm.